Aptadir Therapeutics
Biotechnology Research
Dna Hypermethylation
4 employees
- Employees
- 4
Aptadir Therapeutics Overview
- Headquarters
- Dna Hypermethylation
- Website
- aptadir.com
- Industry
- Biotechnology Research
- Employees
- 4
- Funding
- 1.6M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Aptadir Therapeutics
We discovered a new class of specialized RNAs interacting with the mammalian DNMT1 – DNMT1-interacting RNAs (DiRs). DiRs prevent DNA methylation and gene silencing in a locus-specific manner, by binding and inhibiting DNMT1 are able to reactivate suppressed genes
Aptadir Therapeutics Contact Details
- People in AeroLeads
- 2
Aptadir Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Simone Braggio | Executive Vice President, Head of Partnership Management Excellence (Pme) at Evotec |
View
|
|
| Marcin Kortylewski | Professor @ City of Hope - Tumor Immunology, Oligonucleotide Therapeutics |
View
|
Compare Similar Companies to Aptadir Therapeutics
Wave Life Sciences
Biotechnology Research
CAMP4 Therapeutics
Biotechnology Research
Constructive Bio
Biotechnology Research
Angelini Ventures
Venture Capital And Private Equity Principals
LIfT BioSciences
Biotechnology Research
Genespire
Biotechnology Research
Lucid Genomics
Biotechnology Research
Extend | the National Technology Transfer Biotech Hub
Venture Capital And Private Equity Principals
Polku Therapeutics
Biotechnology Research
NovyStem
Biotechnology Research